You just read:

GW Pharmaceuticals and its U.S. Subsidiary Greenwich Biosciences Announce Publication of Groundbreaking Study of Epidiolex® (cannabidiol) in The New England Journal of Medicine

News provided by

GW Pharmaceuticals plc

25 May, 2017, 08:00 BST